TickerFacts.

Raphael Pharmaceutical Inc. (RAPH): EPS (Diluted)

Annual figures by period end, from SEC filings.

$0.07
Year ended 2025-12-31
-32.7%
3-year compound annual growth
$0.232021-12-31: $0.152022-12-31: $0.232023-12-31: $0.082024-12-31: $0.082025-12-31: $0.07$0.07
2021-12-31 EPS (Diluted) (USD per share) 2025-12-31
Period endedEPS (Diluted)Change YoYSource filing
2025-12-31$0.07-12.5%2026-03-31, From 2025-01-01
2024-12-31$0.080.0%2026-03-31, From 2024-01-01
2023-12-31$0.08-65.2%2025-03-31, From 2023-01-01
2022-12-31$0.23+53.3%2024-03-28, From 2022-01-01
2021-12-31$0.15n/a2023-05-25, From 2021-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Raphael Pharmaceutical Inc. (RAPH)2025-12-31$0.07-12.5%
China Foods Holdings Ltd. (CFOO)2025-12-31-$0.02n/m
Nutra Pharma Corp (NPHC)2025-12-31$0.00n/a
Adia Nutrition, Inc. (ADIA)2025-12-31$0.00n/a
TFA Therapeutics, Inc. (RAJAF)2025-12-31$0.00n/a
Regencell Bioscience Holdings Ltd (RGC)2025-06-30-$0.72n/m
Target Group Inc. (CBDY)2025-12-31$0.00n/m
Functional Brands Inc. (MEHA)2025-12-31$0.01n/m
Synergy CHC Corp. (SNYRQ)2025-12-31-$1.27n/m

Compare RAPH, CFOO, NPHC, ADIA side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗